Form 8-K - Current report:
SEC Accession No. 0001140361-24-048915
Filing Date
2024-12-10
Accepted
2024-12-10 16:15:15
Documents
17
Period of Report
2024-12-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20039817_8k.htm   iXBRL 8-K 26363
2 EXHIBIT 99.1 ef20039817_ex99-1.htm EX-99.1 8014
6 image00001.jpg GRAPHIC 4175
7 image00002.jpg GRAPHIC 6005
8 image00003.jpg GRAPHIC 3028
  Complete submission text file 0001140361-24-048915.txt   189887

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcpc-20241209.xsd EX-101.SCH 3980
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcpc-20241209_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcpc-20241209_pre.xml EX-101.PRE 16043
19 EXTRACTED XBRL INSTANCE DOCUMENT ef20039817_8k_htm.xml XML 4056
Mailing Address 5 PARAGON DRIVE MONTVALE NJ 07645
Business Address 5 PARAGON DRIVE MONTVALE NJ 07645 (845) 326-5600
BALCHEM CORP (Filer) CIK: 0000009326 (see all company filings)

EIN.: 132578432 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13648 | Film No.: 241538653
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)